戴津的增强记忆的作用,可能是通过多巴胺和ACHERGIC依赖途径
Muhammad Torequl Islam1, Abdullah Al Shamsh Prottay2, Md Shimul Bhuia2
1Pharmacy Discipline, Khulna University, Khulna 9208, Bangladesh; Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
The Journal of nutrition
|May 5, 2025
概括
大豆异黄大津 (DZN) 通过与乙胆酶和多巴胺受体相互作用,增强小鼠的记忆力,这表明它是一种用于认知增强的新治疗机制.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在动物研究中,大豆异黄大津 (DZN) 显示出增强认知效果.
- 在DZN的认知效益背后的确切机制尚不清楚.
研究的目的:
- 为了研究DZN的增强记忆能力.
- 探索DZN对认知的影响的潜在机制.
主要方法:
- 动物模型:大理石埋葬,除尘和小鼠的开放场测试 (OFT).
- 在体研究中评估关键受体的结合亲和力.
- 剂量依赖的DZN (5,10,20 mg/kg) 和多巴胺和胺的同时使用.
主要成果:
- DZN显著增加了大理石埋葬和除尘行为.
- 根据剂量,DZN减少了OFT中所行驶的总距离.
- 在分析显示,DZN与乙胆酶 (AChE) 和多巴胺受体 (D1,D3,D5) 有着强烈的结合.
结论:
- 戴津 (DZN) 在小鼠模型中展示了增强记忆的特性.
- DZN的作用机制可能涉及与乙胆酶和多巴胺受体的相互作用.
- 这些发现表明DZN是潜在的治疗因子,用于认知障碍.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
88
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
88
Role of Neurotransmitters in Memory
359
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
359
Adrenergic Agonists: Indirect-Acting Agents
1.4K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.4K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
600
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
600


